Time to abandon microalbuminuria? (Q36548334)

14 August 2017

1 reference

title

Time to abandon microalbuminuria? (English)

1 reference

14 August 2017

2

Remuzzi G

1 reference

14 August 2017

1

Ruggenenti P

1 reference

14 August 2017

language of work or name

English

0 references

publication date

26 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

70

1 reference

14 August 2017

issue

7

1 reference

14 August 2017

page(s)

1214-1222

1 reference

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microalbuminuria: An Early Marker of Renal Involvement in Diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Urinary albumin excretion. An independent predictor of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

'Hypertension' and 'microalbuminuria': the bell tolls for thee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Which albumin should we measure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes: evidence of a sex-specific association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Insulin Resistance and Microalbuminuria: A Cross-Sectional, Case-Control Study of 158 Patients With Type 2 Diabetes and Different Degrees of Urinary Albumin Excretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Antihypertensive therapy and endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Effects of angiotensin II receptor antagonist on endothelial vasomotor function and urinary albumin excretion in type 2 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Local intimal-medial uptakes of 125I-albumin, 125I-LDL, and parenteral Evans blue dye protein complex along the aortas of normocholesterolemic minipigs as predictors of subsequent hypercholesterolemic atherogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Influence of glucose control, lipoproteins, and haemostasis function on brachial endothelial reactivity and carotid intima-media area, stiffness and diameter in Type 1 diabetes mellitus patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Angiotensin II type 1-receptor mediated changes in heparan sulfate proteoglycans in human SV40 transformed podocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microheterogeneity of urinary albumin and tubular proteinuria in juvenile diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Receptor-mediated endocytosis of albumin by kidney proximal tubule cells is regulated by phosphatidylinositide 3-kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Obesity, insulin resistance, and its link to non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Insulin resistance, elevated glomerular filtration fraction, and renal injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Combined renal effects of overweight and hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Obesity, salt intake, and renal perfusion in healthy humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Renal function and body composition before and after intestinal bypass operation in obese patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Glomerular hemodynamics in severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

The effects of weight loss on renal function in patients with severe obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Obesity-associated focal segmental glomerulosclerosis: pathological features of the lesion and relationship with cardiomegaly and hyperlipidemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

The effect of insulin on renal sodium metabolism. A review with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Plasma protein handling in the rat kidney: Micropuncture experiments in the acute heterologous phase of Anti-GBM-nephritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

The metabolic syndrome and chronic kidney disease in U.S. adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microvascular involvement in cardiac pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Glomeruli and blood pressure. Less of one, more the other?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Trajectories of growth among children who have coronary events as adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Nephron number in patients with primary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microalbuminuria in adults after prenatal exposure to the Dutch famine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Microalbuminuria in patients with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

How to protect the kidney in diabetic patients: with special reference to IDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Nephrotoxicity of increased glomerular protein traffic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Tubular catabolism of albumin is associated with the release of an inflammatory lipid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Renal toxicity of albumin and other lipoproteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Structural-functional relationships in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Progression of overt nephropathy in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Understanding the nature of renal disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Progression, remission, regression of chronic renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001729

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5001729

1 reference

14 August 2017

1 reference